Cargando…
Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
AIMS/HYPOTHESIS: Variation in fasting plasma glucose (FPG) within the normal range is a known risk factor for the development of type 2 diabetes. Several reports have shown that genetic variation in the genes for glucokinase (GCK), glucokinase regulatory protein (GCKR), islet-specific glucose 6 phos...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723681/ https://www.ncbi.nlm.nih.gov/pubmed/19533084 http://dx.doi.org/10.1007/s00125-009-1413-9 |
_version_ | 1782170372345430016 |
---|---|
author | Reiling, E. van ’t Riet, E. Groenewoud, M. J. Welschen, L. M. C. van Hove, E. C. Nijpels, G. Maassen, J. A. Dekker, J. M. ’t Hart, L. M. |
author_facet | Reiling, E. van ’t Riet, E. Groenewoud, M. J. Welschen, L. M. C. van Hove, E. C. Nijpels, G. Maassen, J. A. Dekker, J. M. ’t Hart, L. M. |
author_sort | Reiling, E. |
collection | PubMed |
description | AIMS/HYPOTHESIS: Variation in fasting plasma glucose (FPG) within the normal range is a known risk factor for the development of type 2 diabetes. Several reports have shown that genetic variation in the genes for glucokinase (GCK), glucokinase regulatory protein (GCKR), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2) and melatonin receptor type 1B (MTNR1B) is associated with FPG. In this study we examined whether these loci also contribute to type 2 diabetes susceptibility. METHODS: A random selection from the Dutch New Hoorn Study was used for replication of the association with FGP (2,361 non-diabetic participants). For the genetic association study we extended the study sample with 2,628 participants with type 2 diabetes. Risk allele counting was used to calculate a four-gene risk allele score for each individual. RESULTS: Variants of the GCK, G6PC2 and MTNR1B genes but not GCKR were associated with FPG (all, p ≤ 0.001; GCKR, p = 0.23). Combining these four genes in a risk allele score resulted in an increase of 0.05 mmol/l (0.04–0.07) per additional risk allele (p = 2 × 10(−13)). Furthermore, participants with less than three or more than five risk alleles showed significantly different type 2 diabetes susceptibility compared with the most common group with four risk alleles (OR 0.77 [0.65–0.93], p = 0.005 and OR 2.05 [1.50–2.80], p = 4 × 10(−6) respectively). The age at diagnosis was also significantly associated with the number of risk alleles (p = 0.009). CONCLUSIONS: A combined risk allele score for single-nucleotide polymorphisms in four known FPG loci is significantly associated with FPG and HbA(1c) in a Dutch population-based sample of non-diabetic participants. Carriers of low or high numbers of risk alleles show significantly different risks for type 2 diabetes compared with the reference group. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-009-1413-9) contains supplementary material, which is available to authorised users. |
format | Text |
id | pubmed-2723681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-27236812009-08-10 Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk Reiling, E. van ’t Riet, E. Groenewoud, M. J. Welschen, L. M. C. van Hove, E. C. Nijpels, G. Maassen, J. A. Dekker, J. M. ’t Hart, L. M. Diabetologia Article AIMS/HYPOTHESIS: Variation in fasting plasma glucose (FPG) within the normal range is a known risk factor for the development of type 2 diabetes. Several reports have shown that genetic variation in the genes for glucokinase (GCK), glucokinase regulatory protein (GCKR), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2) and melatonin receptor type 1B (MTNR1B) is associated with FPG. In this study we examined whether these loci also contribute to type 2 diabetes susceptibility. METHODS: A random selection from the Dutch New Hoorn Study was used for replication of the association with FGP (2,361 non-diabetic participants). For the genetic association study we extended the study sample with 2,628 participants with type 2 diabetes. Risk allele counting was used to calculate a four-gene risk allele score for each individual. RESULTS: Variants of the GCK, G6PC2 and MTNR1B genes but not GCKR were associated with FPG (all, p ≤ 0.001; GCKR, p = 0.23). Combining these four genes in a risk allele score resulted in an increase of 0.05 mmol/l (0.04–0.07) per additional risk allele (p = 2 × 10(−13)). Furthermore, participants with less than three or more than five risk alleles showed significantly different type 2 diabetes susceptibility compared with the most common group with four risk alleles (OR 0.77 [0.65–0.93], p = 0.005 and OR 2.05 [1.50–2.80], p = 4 × 10(−6) respectively). The age at diagnosis was also significantly associated with the number of risk alleles (p = 0.009). CONCLUSIONS: A combined risk allele score for single-nucleotide polymorphisms in four known FPG loci is significantly associated with FPG and HbA(1c) in a Dutch population-based sample of non-diabetic participants. Carriers of low or high numbers of risk alleles show significantly different risks for type 2 diabetes compared with the reference group. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-009-1413-9) contains supplementary material, which is available to authorised users. Springer-Verlag 2009-06-17 2009-09 /pmc/articles/PMC2723681/ /pubmed/19533084 http://dx.doi.org/10.1007/s00125-009-1413-9 Text en © The Author(s) 2009 |
spellingShingle | Article Reiling, E. van ’t Riet, E. Groenewoud, M. J. Welschen, L. M. C. van Hove, E. C. Nijpels, G. Maassen, J. A. Dekker, J. M. ’t Hart, L. M. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk |
title | Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk |
title_full | Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk |
title_fullStr | Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk |
title_full_unstemmed | Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk |
title_short | Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk |
title_sort | combined effects of single-nucleotide polymorphisms in gck, gckr, g6pc2 and mtnr1b on fasting plasma glucose and type 2 diabetes risk |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723681/ https://www.ncbi.nlm.nih.gov/pubmed/19533084 http://dx.doi.org/10.1007/s00125-009-1413-9 |
work_keys_str_mv | AT reilinge combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk AT vantriete combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk AT groenewoudmj combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk AT welschenlmc combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk AT vanhoveec combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk AT nijpelsg combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk AT maassenja combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk AT dekkerjm combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk AT thartlm combinedeffectsofsinglenucleotidepolymorphismsingckgckrg6pc2andmtnr1bonfastingplasmaglucoseandtype2diabetesrisk |